Skip to content

Current ratio at other companies

IAR
Integra LifeSciencesIART
3.4×+2.2×
MiMedx Group logo
MiMedx GroupMDXG
5.4×+0.7×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
2.9×+0.2×
Bioventus logo
BioventusBVS
1.7×+0.3×
Artivion logo
ArtivionAORT
3.9×-1.7×
Axogen logo
AxogenAXGN
7.1×+2.8×

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Based on the most recent quarter.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s current ratio?
Organogenesis Holdings Inc. (ORGO) reported current ratio of 3.5× in Q1 2026.
How has Organogenesis Holdings Inc.'s current ratio changed year-over-year?
Organogenesis Holdings Inc.'s current ratio decreased by 14.3% year-over-year, from 4.1× to 3.5×.
What is the long-term trend for Organogenesis Holdings Inc.'s current ratio?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s current ratio has grown at a 7.2% compound annual growth rate (CAGR), from 2.6× to 3.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.